Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07511413 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients

Study acronym: GALENOS 1
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
GALENOS 1 is a prospective observational study designed to explore longitudinal changes in nutritional status and body composition in patients with head and neck squamous cell carcinoma, locally advanced rectal cancer, and lung cancer undergoing standard antineoplastic treatments. The study is the preparatory observational component of the FOR-GALE PREVENTION project, which aims to support the future development of a galenic immunonutrition dietary supplement intended to reduce adverse events and improve treatment compliance
Trial Details
NCT Number NCT07511413
Lead Sponsor Fondazione del Piemonte per l'Oncologia
Conditions
(from sponsor)		 Head and Neck Squamous Cell Carcinoma, Locally Advanced Rectal Cancer, Lung Cancer
Related terms Lung Neoplasms, Sarcopenia, Squamous Cell Carcinoma of Head and Neck
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov